SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-245623
Filing Date
2022-09-15
Accepted
2022-09-15 16:11:05
Documents
16
Period of Report
2022-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d385403d8k.htm   iXBRL 8-K 34900
2 EX-5.1 d385403dex51.htm EX-5.1 8678
3 EX-10.1 d385403dex101.htm EX-10.1 190880
8 GRAPHIC g385403dsp5.jpg GRAPHIC 8602
  Complete submission text file 0001193125-22-245623.txt   458836

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA celu-20220915.xsd EX-101.SCH 3912
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20220915_def.xml EX-101.DEF 13679
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20220915_lab.xml EX-101.LAB 22574
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20220915_pre.xml EX-101.PRE 14641
10 EXTRACTED XBRL INSTANCE DOCUMENT d385403d8k_htm.xml XML 5340
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 221245902
SIC: 2834 Pharmaceutical Preparations